Stents in the heart
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Coronary Artery Stents in Heart Disease Treatment
Introduction to Coronary Artery Stents
Coronary artery stents are small, tubular devices inserted into coronary arteries to keep them open and ensure adequate blood flow to the heart muscle. They are primarily used to treat ischemic heart disease (IHD), which is a leading cause of morbidity and mortality worldwide . The use of stents has significantly increased over the past decades, becoming a common procedure in percutaneous coronary interventions (PCIs).
Types of Stents: Bare-Metal, Drug-Eluting, and Bioresorbable
Bare-Metal Stents (BMS)
Bare-metal stents were the first generation of stents used in coronary artery disease treatment. They are made of metal and provide structural support to the artery. However, they have a higher risk of restenosis, where the artery narrows again due to tissue growth around the stent .
Drug-Eluting Stents (DES)
To address the issue of restenosis, drug-eluting stents were developed. These stents are coated with medication that is slowly released to prevent excessive tissue growth. DES have been shown to reduce the rates of restenosis and the need for repeat revascularization procedures compared to BMS . Despite their higher initial cost, DES are considered cost-effective in the long term due to their improved clinical outcomes.
Bioresorbable Stents
The latest innovation in stent technology is bioresorbable stents, which are designed to dissolve over time, leaving no permanent foreign material in the body. These stents aim to provide temporary support to the artery while reducing long-term complications associated with permanent stents . However, their adoption is still limited, and further research is needed to fully understand their long-term benefits and risks.
Effectiveness and Cost-Effectiveness of Stents
Comparison with Percutaneous Transluminal Coronary Angioplasty (PTCA)
Studies have shown that stents are more effective than PTCA alone in preventing adverse events and the need for repeat revascularization procedures. Stents provide better outcomes in terms of event-free survival and reduced rates of myocardial infarction and angina .
Comparison with Coronary Artery Bypass Graft (CABG)
In patients with multiple-vessel disease, there is no significant difference in mortality between those treated with stents and those undergoing CABG. However, CABG patients tend to require fewer revascularizations over time. The initial costs of CABG are higher, but the long-term outcomes may favor this surgical approach over stenting in complex cases.
Stents in Congenital Heart Disease
Stents are also used in the treatment of congenital heart disease (CHD), providing a minimally invasive alternative to open-heart surgery. They are particularly useful in treating postoperative stenoses and other vascular abnormalities in pediatric patients . Despite the challenges of using adult stents in children, the outcomes have been generally positive, with significant improvements in vessel patency and pressure gradients .
Future Directions and Innovations
The field of stent technology is continuously evolving, with ongoing research focused on improving materials, coatings, and designs to enhance biocompatibility, reduce complications, and improve patient outcomes. Innovations such as drug-eluting coatings, bioresorbable materials, and advanced manufacturing techniques hold promise for the future of stent therapy .
Conclusion
Coronary artery stents have revolutionized the treatment of ischemic heart disease and congenital heart disease, offering effective and minimally invasive options for patients. While challenges remain, particularly in the long-term management of stented patients, ongoing advancements in stent technology continue to improve clinical outcomes and expand the possibilities for cardiovascular interventions.
Sources and full results
Most relevant research papers on this topic